← All organizations
Highest phase reached
Phase 4
Timeline
1970s
- Jun 29, 1979
Boston Scientific Corporation— Founded
1990s
- Mar 25, 1994
levodopa— Marketing Organization
2000s
- Apr 21, 2006
Guidant Corporation— Acquired
2020s
- Sep 19, 2023
Relievant Medsystems, Inc.— Acquired
Drugs by trial phase (66 distinct, 87 trials)
Phase 4 (15 own, 7 via acquisition)
Phase 3 (5 own, 5 via acquisition)
Phase 2 (0 own, 21 via acquisition)
Phase 1 (0 own, 7 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Arterial Occlusive Diseases
- Atherosclerosis
- Atrial Fibrillation
- Coronary Artery Disease
- Coronary Disease
- Heart Diseases
- Infarction
- Myocardial Infarction
- Myocardial Ischemia
- Peripheral Arterial Disease
- Plaque, Atherosclerotic
- Postphlebitic Syndrome
- Postthrombotic Syndrome
- ST Elevation Myocardial Infarction
- Syndrome
- Thromboembolism
- Thrombosis
- Venous Thromboembolism
- Venous Thrombosis
Marketed drugs (5)
Subsidiaries (4 direct, 13 total across the full acquisition tree)
Recent trials (40)
- NCT07122089CollaboratorPhase 2Jan 2, 2026
- NCT06765356CollaboratorPhase 4Jan 30, 2025
- NCT06096337Lead sponsorN/ADec 15, 2023
- NCT05709626CollaboratorPhase 4Feb 28, 2023
- NCT05312970Lead sponsorPhase 4Dec 31, 2022
- NCT05063565Lead sponsorPhase 2Dec 31, 2021
- NCT05016245Lead sponsorPhase 3Sep 24, 2021
- NCT06218199CollaboratorPhase 4Jul 8, 2021
- NCT04790370Lead sponsorPhase 4Jul 1, 2021
- NCT04694248CollaboratorN/AJun 1, 2021
- NCT05117866CollaboratorN/ASep 15, 2020
- NCT03606642CollaboratorPhase 2Jul 23, 2018
- NCT03048825CollaboratorPhase 3Jun 30, 2017
- NCT03064126Lead sponsorPhase 3Mar 2, 2017
- NCT02764203Lead sponsorN/ASep 16, 2016
Details
- Founded
- Marlborough, MA, US Jun 29, 1979
- Last known activity
- Jan 2, 2026